The Polyamines: Small Molecules in the ‘Omics’ Era

Metabolism is altered significantly in diseases such as cancer, resulting in the pathway being identified as a target for the design of anticancer drugs. A recent upsurge in interest in the polyamines, including the development of transgenic models, has highlighted the biochemical importance of these molecules.